Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1992-1-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0893-6692
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
307
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading | |
pubmed:year |
1991
|
pubmed:articleTitle |
Emerging technologies--the use of transgenic mice for assessing mutagenic potential in vivo.
|
pubmed:affiliation |
Miami Valley Laboratories, Procter and Gamble Company, Cincinnati, Ohio 45239-8707.
|
pubmed:publicationType |
Journal Article
|